December
November
October
September
August
July
June
May
April
March
February
January
Scope of the journal
Scope of the Journal involves Molecular Pathobiology, cellular pathobiology, tumor and stem cell biology, metastasis, tumor suppressor, microenvironment and immunology, prevention and epidemiology, integrated systems and technology, therapeutics and targets. View More..Special Sections 
Articles published in the journal will also be included under the special section that falls within the scope of each section. The special sections are as follows:
Cancer stem cells | Innovative Therapies
Carcinogenesis | Organ Specific Cancers
Radiation and Imaging
Epidemiology, Genetics and Genomics
Original ResearchOpen Access
Original ResearchOpen Access
Original ResearchOpen Access
Original ResearchOpen Access
ReviewOpen Access
Original ResearchOpen Access
Original ResearchOpen Access
Original ResearchOpen Access
Original ResearchOpen Access
Short reportOpen Access
View All articles ..
Pancreatic Cancer Incidence, Mortality, and Survival in the SEER 17 Southern and Total United States (2000-2008)
Subi GandhiJournal of Cancer Therapeutics & Research 6 : 3
Original ResearchOpen Access
Expression of circulating annexin A2 in hepatic diseases and hepatocellular carcinoma
Ebtesam El-Gezawy, Laila Abdelbaki, Mohamed Zeinel Deen, Sahar Eldeek, Marwa I AbdelgawadJournal of Cancer Therapeutics & Research 6 : 2
Original ResearchOpen Access
The role of simvastatin in inhibiting migration and proliferation of breast cancer cells through Rho/ROCK signaling pathway
Erwin Danil Yulian, Muchlis Ramli, Rianto Setiabudy, Nurjati Chairani Siregar, Arleni Bustami, Ricky DosanJournal of Cancer Therapeutics & Research 5 : 10
Original ResearchOpen Access
Spiritual pain from persistent chemotherapy-induced peripheral neuropathy in colon cancer patients in Japan
Ayumi Kyota, Kiyoko Kanda, Masako Honda, Kenji Nakazawa, Keiko FujimotoJournal of Cancer Therapeutics & Research 5 : 9
ReviewOpen Access
The intersection of chance with determinism: definitions and an application
Ken M Anderson, Marvin Rubenstein, Minu PatelJournal of Cancer Therapeutics & Research 5 : 8
Original ResearchOpen Access
Aberrant NHERF1 expression as a biomarker in lung carcinoma
Deborah Belchis, Nathan Cuka, Neeraj Sharma, Rajni Sharma, Christopher D GockeJournal of Cancer Therapeutics & Research 5 : 7
Original ResearchOpen Access
Adjuvant intravesical instillation for primary intermediate and high-risk non-muscle invasive bladder cancer: BCG versus docetaxel
Hoda H Essa, Ahmed M Abd-AlrahimJournal of Cancer Therapeutics & Research 5 : 6
Original ResearchOpen Access
Selective bladder preserving treatment by radiation therapy concurrent with either paclitaxel and cisplatin or cisplatin alone following a transurethral surgery
Reham Abdel-Wahab, Hoda H Essa, Ahmed Eltaher, Nagham N Omar, Mohamed A AboziadaJournal of Cancer Therapeutics & Research 5 : 5
Original ResearchOpen Access
Concurrent radiation therapy and docetaxel in adjuvant treatment of locally advanced breast cancer
Samy M Algizawy, Hoda H Essa, AbdelNaser S ZaidJournal of Cancer Therapeutics & Research 5 : 4
Short reportOpen Access
New York state health care provider participation in clinical trials: a brief report
Pathu Sriphanlop, Danielle M Crookes, Karen Demairo, Darryl Somayaji, Maureen Killackey, Anita McFarlane, Jean LePere, Lina JandorfJournal of Cancer Therapeutics & Research 5 : 3
View All articles ..
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Editor-in-Chief

acting Head for the Laboratory Medical Oncology, VU University Medical Center, Netherlands. The major research interests of Prof. Peters include all aspects of pharmacology of anticancer agents, with emphasis on antifolates, other antimetabolites, platinum analogs, taxanes and more recently anti-signalling agents and third generation targeted-agents.
Senior Editors

is presently acting as a Coordinator for IOR Director of the Laboratory of Experimental Oncology and President of the Italian Sarcoma Group and Director Laboratory of Experimental Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy. Dr. Piero is founder and member of the Board of the "Association for Study and Research in Musculo-skeletal Tumors". His major interest are focused on Diagnosis of bone tumors, Musculo-skeletal oncology, Bone tumors and Paediatric orthopaedic oncology.

Professor of Cancer Biology, Medical Oncology and Pathology at Thomas Jefferson University, Philadelphia, PA. He serves as the Scientific Director of the Jefferson Breast Care Center and is the Leader of Kimmel Cancer Center's Biology of Breast Cancer Program. Dr. Rui and his team have invented new high-density tissue arraying technology for high-throughput in situ biomarker studies. His major research interest focused on prolactin-JAK-STAT signaling in breast cancer, Loss of active STAT5 is an independent marker of poor prognosis and also an independent predictive marker of resistance to antiestrogen therapy.

Professor of Cancer Biology, Jefferson Kimmel Cancer Center. He has completed his Ph.D. in Pediatrics, University of Turin School of Medicine, Torino, Italy. He is been acting as Adjunct Associate Professor of Pediatrics, University of Pennsylvania School of Medicine. His major research and Clinical Interest are focused on Genomics, technology and assay development in genomics, SNP genotype and CNV analysis for GWAS, gene discovery, pharmacogenomics .

Professor Of Cariology, Restorative Sciences, and Endodontics School of Dentistry, University of Michigan. He is been Honorary Professor, Oral Biology, University of Birmingham, UK. Dr. Nör research interests are focused on the cellular and molecular regulation of tumor angiogenesis. In addition, his research group has worked on the use of stem cells for the engineering of dental pulps.

Director, Urologic Pathology, Professor of Pathology and Laboratory Medicine. Dr. Jiaoti has Hospital Affiliation from Ronald Reagan UCLA Medical Center, USA. His research interested is majorly focused on Genitourinary Pathology, Surgical Pathology, Urologic Pathology.
Journal of Cancer Therapeutics & Research Subject Areas
Cancer Biology, Cancer Therapy, Cancer Prevention, Cancer Epidemiology, Oncology, Cancer Genetics, Cancer Genomics, Translational Therapeutics, Lung Cancer, Breast Cancer, Colorectal Cancer,
Hepatocellular Carcinoma , Genitourinary Cancer, Gynecologic Cancer, Central Nervous System Tumors, Head and Neck Cancer, Lymphoma, Skin Cancers.